[go: up one dir, main page]

DK2414838T3 - Anti-knogletab og anti-fastgøringstab effekter fra en oral forbindelse - Google Patents

Anti-knogletab og anti-fastgøringstab effekter fra en oral forbindelse

Info

Publication number
DK2414838T3
DK2414838T3 DK10712854.8T DK10712854T DK2414838T3 DK 2414838 T3 DK2414838 T3 DK 2414838T3 DK 10712854 T DK10712854 T DK 10712854T DK 2414838 T3 DK2414838 T3 DK 2414838T3
Authority
DK
Denmark
Prior art keywords
loss
oral
relationship
effects
bone
Prior art date
Application number
DK10712854.8T
Other languages
English (en)
Inventor
Virginia Barnes
Harsh M Trivedi
Wei Wang
Tao Xu
Emi Shimizu
Nicola C Partridge
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2414838(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK2414838T3 publication Critical patent/DK2414838T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK10712854.8T 2009-04-01 2010-04-01 Anti-knogletab og anti-fastgøringstab effekter fra en oral forbindelse DK2414838T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16568509P 2009-04-01 2009-04-01
PCT/US2010/029670 WO2010115031A1 (en) 2009-04-01 2010-04-01 Anti bone-loss and anti attachment-loss effects of an oral composition

Publications (1)

Publication Number Publication Date
DK2414838T3 true DK2414838T3 (da) 2013-11-04

Family

ID=42328354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10712854.8T DK2414838T3 (da) 2009-04-01 2010-04-01 Anti-knogletab og anti-fastgøringstab effekter fra en oral forbindelse

Country Status (20)

Country Link
US (1) US8637266B2 (da)
EP (1) EP2414838B1 (da)
JP (1) JP5330596B2 (da)
CN (1) CN102365550B (da)
AR (1) AR076177A1 (da)
AU (1) AU2010232590B2 (da)
BR (1) BRPI1013185A2 (da)
CA (1) CA2757317C (da)
CO (1) CO6420374A2 (da)
DK (1) DK2414838T3 (da)
ES (1) ES2432864T3 (da)
HK (1) HK1167272A1 (da)
MX (1) MX2011008438A (da)
MY (1) MY158406A (da)
PL (1) PL2414838T3 (da)
RU (1) RU2524629C2 (da)
SG (1) SG173487A1 (da)
TW (1) TWI405565B (da)
WO (1) WO2010115031A1 (da)
ZA (1) ZA201106054B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101745067B1 (ko) * 2014-12-31 2017-06-12 서울대학교산학협력단 치주질환 예측 시스템 및 이를 이용한 치주질환 예측 방법
KR102098624B1 (ko) * 2019-09-20 2020-04-08 서울대학교산학협력단 타액 mmp-9 및 il-8를 이용한 치주염 예측 시스템 및 이를 이용한 치주염 예측 방법

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
US5032386A (en) 1988-12-29 1991-07-16 Colgate-Palmolive Company Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5840302A (en) 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
WO1997047282A1 (de) 1996-06-12 1997-12-18 Henkel Kommanditgesellschaft Auf Aktien Kosmetische und/oder pharmazeutische zubereitungen
US5998487A (en) * 1998-04-08 1999-12-07 Colgate-Palmolive Company Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6165447A (en) * 1999-06-15 2000-12-26 Colgate-Palmolive Company Synergistic antibacterial combination
EP2295968B1 (en) 1999-12-03 2012-09-19 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP1285092A4 (en) 2000-04-14 2003-07-16 Metabolon Inc METHOD FOR DISCOVERY OF MEDICINES, DISEASE TREATMENT AND DIAGNOSIS USE THE METABOLOMICS
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
MXPA05001786A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados de azaisoquinolina como inhibidores de la metaloproteinasa de matriz.
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
PL378108A1 (pl) 2003-02-14 2006-03-06 Combinatorx, Incorporated Leczenie łączone do terapii zapalnych zaburzeń immunologicznych
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
EP1697389A4 (en) 2003-10-24 2008-12-24 Eisai R&D Man Co Ltd COMPOUNDS AND METHODS FOR TREATING ILLNESS AND SUFFERING TOLL-LIKE RECEPTOR 2 RELATED DISORDERS
JP2007519894A (ja) 2003-12-03 2007-07-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ 標的としてのカドヘリンの使用
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
JP4662043B2 (ja) * 2004-09-09 2011-03-30 国立大学法人東京農工大学 歯周病発症の評価システム
CN101111288A (zh) * 2004-12-02 2008-01-23 高露洁-棕榄公司 含酚类化合物和抗氧化剂维生素和维生素衍生物的口腔护理组合物
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP5024506B2 (ja) * 2005-03-25 2012-09-12 ライオン株式会社 歯周組織破壊の抑制・改善剤及び口腔用組成物
CA2849559A1 (en) 2006-01-10 2007-07-19 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
WO2009048841A1 (en) 2007-10-09 2009-04-16 Humco Holding Group, Inc. Antifungal treatment of nails
TWI481870B (zh) * 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記

Also Published As

Publication number Publication date
AU2010232590A1 (en) 2011-08-18
AU2010232590B2 (en) 2013-03-07
ES2432864T3 (es) 2013-12-05
CN102365550B (zh) 2014-08-13
WO2010115031A1 (en) 2010-10-07
TWI405565B (zh) 2013-08-21
JP5330596B2 (ja) 2013-10-30
EP2414838A1 (en) 2012-02-08
CO6420374A2 (es) 2012-04-16
PL2414838T3 (pl) 2014-01-31
AR076177A1 (es) 2011-05-26
MY158406A (en) 2016-10-14
HK1167272A1 (en) 2012-11-23
EP2414838B1 (en) 2013-08-28
US20120107843A1 (en) 2012-05-03
CA2757317A1 (en) 2010-10-07
CA2757317C (en) 2014-03-11
TW201039812A (en) 2010-11-16
MX2011008438A (es) 2011-09-06
JP2012524884A (ja) 2012-10-18
RU2011144028A (ru) 2013-05-10
CN102365550A (zh) 2012-02-29
US8637266B2 (en) 2014-01-28
RU2524629C2 (ru) 2014-07-27
SG173487A1 (en) 2011-09-29
BRPI1013185A2 (pt) 2016-04-12
ZA201106054B (en) 2014-01-29

Similar Documents

Publication Publication Date Title
IL272376A (en) Polycyclic compounds and methods of using them
DK2419670T3 (da) Leveringsmetode og sammensætninger
DK3190183T3 (da) Sammensætninger og fremgangsmåder omfattende proteasevarianter
DK3460056T3 (da) Terapeutiske nukleasesammensætninger og fremgangsmåder
HUE057713T2 (hu) A protein A (SPA) variánsaival kapcsolatos készítmények és módszerek
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2513193T3 (da) Forbedrede blends af polyarylenethere og polyarylensulfider
DK2419732T3 (da) Prionfrie nanopartikelsammensætninger og fremgangsmåder
DK3031445T3 (da) Sublinguale og bukkale filmsammensætninger
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
HUE046932T2 (hu) Argináz inhibitorok és felhasználási eljárások
DK3202460T3 (da) Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme
DK3848347T3 (da) Fremstilling af glukarsyre og derivater fra glukose
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
DK2408794T3 (da) Isolering og oprensning af vallebestanddele
DK2805746T3 (da) Alkylamido-forbindelser og anvendelser deraf
PT2504298T (pt) Preparação e purificação de iodoxanol
DK2475649T3 (da) Indenonderivat og farmaceutisk sammensætning omfattende samme
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider
LT2506840T (lt) Hipoksija sukeliančio faktoriaus inhibitorių naudojimas
DK2525782T3 (da) Formuleringer af nanobærere og fremgangsmåder til fremstilling deraf
DK2406372T3 (da) Prægastrisk esterase og derivater deraf
UA21424S (uk) Елемент мундштука
DK2473507T3 (da) Stabile sns-595-sammensætninger og fremgangsmåder til fremstilling
DK2482799T3 (da) Farmaceutiske aerosolformuleringer af formoterol og beclometasondipropionat